SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-04-002619
Filing Date
2004-11-19
Accepted
2004-11-19 19:39:28
Documents
1
Period of Report
2004-11-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 50408
  Complete submission text file 0001019687-04-002619.txt   52323
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 14272 FRANKLIN AVE. TUSTIN CA 92780
SWARTZ ERIC S (Reporting) CIK: 0001244108 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17085 | Film No.: 041159090